Zobrazeno 1 - 10 of 186 pro vyhledávání: '"Vonarburg C"'
1
Akademický článek
Genome editing with the HDR-enhancing DNA-PKcs inhibitor AZD7648 causes large-scale genomic alterations.
Autor: Cullot G; Department of Biology, Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland. gregoire.cullot@biol.ethz.ch., Aird EJ; Department of Biology, Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland., Schlapansky MF; Department of Biology, Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland., Yeh CD; Department of Biology, Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland., van de Venn L; Department of Biology, Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland., Vykhlyantseva I; Department of Biology, Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland., Kreutzer S; Department of Biology, Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland., Mailänder D; Department of Biology, Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland., Lewków B; Department of Biology, Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland., Klermund J; Institute for Transfusion Medicine and Gene Therapy, Medical Center - University of Freiburg, Freiburg, Germany.; Center for Chronic Immunodeficiency, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Montellese C; CSL Behring Research, Bern, Switzerland.; Swiss Institute for Translational Medicine sitem-insel, Bern, Switzerland., Biserni M; CSL Behring Research, Bern, Switzerland.; Swiss Institute for Translational Medicine sitem-insel, Bern, Switzerland., Aeschimann F; CSL Behring Research, Bern, Switzerland.; Swiss Institute for Translational Medicine sitem-insel, Bern, Switzerland., Vonarburg C; CSL Behring Research, Bern, Switzerland.; Swiss Institute for Translational Medicine sitem-insel, Bern, Switzerland., Gehart H; Department of Biology, Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland., Cathomen T; Institute for Transfusion Medicine and Gene Therapy, Medical Center - University of Freiburg, Freiburg, Germany.; Center for Chronic Immunodeficiency, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Corn JE; Department of Biology, Institute of Molecular Health Sciences, ETH Zurich, Zurich, Switzerland. jacob.corn@biol.ethz.ch.
Publikováno v: Nature biotechnology [Nat Biotechnol] 2024 Nov 27. Date of Electronic Publication: 2024 Nov 27.
Zobrazit plný text záznamu
2
Akademický článek
An optimized protocol for quality control of gene therapy vectors using nanopore direct RNA sequencing.
Autor: Zeglinski K; Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3052, Australia; zeglinski.k@wehi.edu.au., Montellese C; CSL Behring, Research, CH-3014 Bern, Switzerland.; Swiss Institute for Translational Medicine, sitem-insel, 3010 Bern, Switzerland., Ritchie ME; Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3052, Australia., Alhamdoosh M; Research Data Science Group, R&D, CSL, Parkville, Victoria 3000, Australia., Vonarburg C; CSL Behring, Research, CH-3014 Bern, Switzerland.; Swiss Institute for Translational Medicine, sitem-insel, 3010 Bern, Switzerland., Bowden R; Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3052, Australia., Jordi M; CSL Behring, Research, CH-3014 Bern, Switzerland., Gouil Q; Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3052, Australia., Aeschimann F; CSL Behring, Research, CH-3014 Bern, Switzerland.; Swiss Institute for Translational Medicine, sitem-insel, 3010 Bern, Switzerland., Hsu A; Research Data Science Group, R&D, CSL, Parkville, Victoria 3000, Australia.
Publikováno v: Genome research [Genome Res] 2024 Nov 20; Vol. 34 (11), pp. 1966-1975. Date of Electronic Publication: 2024 Nov 20.
Zobrazit plný text záznamu
3
Akademický článek
Airway inflammation and dysbiosis in antibody deficiency despite the presence of IgG.
Autor: Schnell A; CSL Behring, Research Europe, Bern, Switzerland; CSL Behring, Research Europe, Marburg, Germany., Davrandi M; Institute of Immunity and Transplantation, University College London, London, United Kingdom; Centre for Clinical Microbiology, University College London, London, United Kingdom., Saxenhofer M; CSL Behring, Research Europe, Bern, Switzerland; CSL Behring, Research Europe, Marburg, Germany., Leboreiro C; Institute of Immunity and Transplantation, University College London, London, United Kingdom; Centre for Clinical Microbiology, University College London, London, United Kingdom., Graeter S; CSL Behring, Research Europe, Bern, Switzerland; CSL Behring, Research Europe, Marburg, Germany., Moreira F; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom., Hauswald M; CSL Behring, Research Europe, Bern, Switzerland; CSL Behring, Research Europe, Marburg, Germany., Witte C; CSL Behring, Research Europe, Bern, Switzerland; CSL Behring, Research Europe, Marburg, Germany., Irincheeva I; CSL Behring, Research Europe, Bern, Switzerland; CSL Behring, Research Europe, Marburg, Germany., Feussner A; CSL Behring, Research Europe, Bern, Switzerland; CSL Behring, Research Europe, Marburg, Germany., Vonarburg C; CSL Behring, Research Europe, Bern, Switzerland; CSL Behring, Research Europe, Marburg, Germany., Schulze I; CSL Behring, Research Europe, Bern, Switzerland; CSL Behring, Research Europe, Marburg, Germany., Schaub A; CSL Behring, Research Europe, Bern, Switzerland; CSL Behring, Research Europe, Marburg, Germany., Burns SO; Institute of Immunity and Transplantation, University College London, London, United Kingdom; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom., Lowe DM; Institute of Immunity and Transplantation, University College London, London, United Kingdom; Department of Clinical Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom. Electronic address: d.lowe@ucl.ac.uk.
Publikováno v: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2022 Jun; Vol. 149 (6), pp. 2105-2115.e10. Date of Electronic Publication: 2021 Dec 28.
Zobrazit plný text záznamu
4
Akademický článek
Increased Respiratory Viral Detection and Symptom Burden Among Patients with Primary Antibody Deficiency: Results from the BIPAD Study.
Autor: Ponsford MJ; Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, United Kingdom; Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom., Price C; Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, United Kingdom., Farewell D; Division of Population Medicine, School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, United Kingdom., Greene G; Division of Population Medicine, School of Medicine, College of Biomedical and Life Sciences, Cardiff University, Cardiff, United Kingdom., Moore C; Public Health Wales, Cardiff, United Kingdom., Perry M; Public Health Wales, Cardiff, United Kingdom., Price N; Public Health Wales, Cardiff, United Kingdom., Cottrell S; Public Health Wales, Cardiff, United Kingdom., Steven R; Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, United Kingdom., El-Shanawany T; Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, United Kingdom., Carne E; Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, United Kingdom., Cousins R; Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, United Kingdom., Williams P; Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, United Kingdom., Schaub A; CSL Behring AG, Bern, Switzerland., Vonarburg C; CSL Behring AG, Bern, Switzerland., Jolles S; Immunodeficiency Centre for Wales, University Hospital of Wales, Cardiff, United Kingdom. Electronic address: jollessr@cardiff.ac.uk.
Publikováno v: The journal of allergy and clinical immunology. In practice [J Allergy Clin Immunol Pract] 2021 Feb; Vol. 9 (2), pp. 735-744.e6. Date of Electronic Publication: 2020 Aug 22.
Zobrazit plný text záznamu
5
Akademický článek
IgA Triggers Cell Death of Neutrophils When Primed by Inflammatory Mediators.
Autor: Wehrli M; Institute of Pharmacology, University of Bern, 3010 Bern, Switzerland., Schneider C; Institute of Pharmacology, University of Bern, 3010 Bern, Switzerland., Cortinas-Elizondo F; Institute of Pharmacology, University of Bern, 3010 Bern, Switzerland., Verschoor D; Institute of Pharmacology, University of Bern, 3010 Bern, Switzerland., Frias Boligan K; Institute of Pharmacology, University of Bern, 3010 Bern, Switzerland., Adams OJ; Institute of Pharmacology, University of Bern, 3010 Bern, Switzerland., Hlushchuk R; Institute of Anatomy, University of Bern, 3012 Bern, Switzerland., Engelmann C; Viral Immunobiology, Institute of Experimental Immunology, University of Zürich, Zürich, Switzerland., Daudel F; Intensive Care Unit, Spital Thun, 3600 Thun, Switzerland., Villiger PM; Department of Rheumatology/Clinical Immunology/Allergology, University Hospital Bern, 3008 Bern, Switzerland., Seibold F; Gastroenterologie, Spitalnetz Bern, 3004 Bern, Switzerland.; Gastroenterologie, Praxis Balsiger, Seibold und Partner am Lindenhofspital, 3012 Bern, Switzerland., Yawalkar N; Department of Dermatology, University Hospital Bern, University of Bern, 3010 Bern, Switzerland., Vonarburg C; Research, CSL Behring, 3014 Bern, Switzerland., Miescher S; Research, CSL Behring, 3014 Bern, Switzerland., Lötscher M; Research, CSL Behring, 3014 Bern, Switzerland., Kaufmann T; Institute of Pharmacology, University of Bern, 3010 Bern, Switzerland., Münz C; Viral Immunobiology, Institute of Experimental Immunology, University of Zürich, Zürich, Switzerland., Mueller C; Institute of Pathology, University of Bern, 3008 Bern, Switzerland; and., Djonov V; Institute of Anatomy, University of Bern, 3012 Bern, Switzerland., Simon HU; Institute of Pharmacology, University of Bern, 3010 Bern, Switzerland.; Department of Clinical Immunology and Allergology, Sechenov University, Moscow 119991, Russia., von Gunten S; Institute of Pharmacology, University of Bern, 3010 Bern, Switzerland; stephan.vongunten@pki.unibe.ch.
Publikováno v: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2020 Nov 15; Vol. 205 (10), pp. 2640-2648. Date of Electronic Publication: 2020 Oct 02.
Zobrazit plný text záznamu
6
Report
Effect of intravenous IgG therapy on natural killer cell function related to Fc gamma receptor gene expression.
Autor: Papaserafeim M; Division of Immunology and Allergology, University Hospitals and Medical Faculty, Geneva, Switzerland., Jandus P; Division of Immunology and Allergology, University Hospitals and Medical Faculty, Geneva, Switzerland., Iancu Ferfoglia R; Division of Neurology, University Hospitals Geneva, Geneva, Switzerland., Nieke JP; Division of Immunology and Allergology, University Hospitals and Medical Faculty, Geneva, Switzerland., Vonarburg C; CSL Behring AG, CSL Biologics Research Center, Bern, Switzerland., Spirig R; CSL Behring AG, CSL Biologics Research Center, Bern, Switzerland., Puga Yung GL; Division of Immunology and Allergology, University Hospitals and Medical Faculty, Geneva, Switzerland., Seebach JD; Division of Immunology and Allergology, University Hospitals and Medical Faculty, Geneva, Switzerland. Electronic address: joerg.seebach@hcuge.ch.
Publikováno v: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2020 Sep; Vol. 146 (3), pp. 667-670. Date of Electronic Publication: 2020 Apr 18.
Zobrazit plný text záznamu
7
Akademický článek
NK Cytotoxicity Mediated by NK-92 Cell Lines Expressing Combinations of Two Allelic Variants for FCGR3.
Autor: Freitas Monteiro, Marta1 (AUTHOR), Papaserafeim, Maria1 (AUTHOR), Andreani, Matteo1 (AUTHOR), Réal, Aline1 (AUTHOR), Kouklas, Athanasios1 (AUTHOR), Reis Galvão, Daniela1 (AUTHOR), Seebach, Jörg D.1 (AUTHOR) joerg.seebach@hug.ch, Puga Yung, Gisella L.1 (AUTHOR) joerg.seebach@hug.ch
Publikováno v: Antibodies (2073-4468). Sep2024, Vol. 13 Issue 3, p55. 25p.
Zobrazit plný text záznamu
8
Akademický článek
Intravenous immunoglobulin induces IL-4 in human basophils by signaling through surface-bound IgE.
Autor: Galeotti C; Institut National de la Santé et de la Recherche Médicale and Centre de Recherche des Cordeliers, Equipe-Immunopathologie et Immunointervention Thérapeutique, Sorbonne Université, Paris, France; Service de Rhumatologie Pédiatrique, Centre de Référence des Maladies Auto-Inflammatoires rares et des Amyloses, CHU de Bicêtre, Le Kremlin Bicêtre, France., Stephen-Victor E; Institut National de la Santé et de la Recherche Médicale and Centre de Recherche des Cordeliers, Equipe-Immunopathologie et Immunointervention Thérapeutique, Sorbonne Université, Paris, France., Karnam A; Institut National de la Santé et de la Recherche Médicale and Centre de Recherche des Cordeliers, Equipe-Immunopathologie et Immunointervention Thérapeutique, Sorbonne Université, Paris, France., Das M; Institut National de la Santé et de la Recherche Médicale and Centre de Recherche des Cordeliers, Equipe-Immunopathologie et Immunointervention Thérapeutique, Sorbonne Université, Paris, France., Gilardin L; Institut National de la Santé et de la Recherche Médicale and Centre de Recherche des Cordeliers, Equipe-Immunopathologie et Immunointervention Thérapeutique, Sorbonne Université, Paris, France; Département de Médecine Interne et Immunologie Clinique, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France., Maddur MS; Institut National de la Santé et de la Recherche Médicale and Centre de Recherche des Cordeliers, Equipe-Immunopathologie et Immunointervention Thérapeutique, Sorbonne Université, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France., Wymann S; Research Department, CSL Behring AG, Bern, Switzerland., Vonarburg C; Research Department, CSL Behring AG, Bern, Switzerland., Chevailler A; Laboratoire d'Immunologie et d'Allergologie, CHU d'Angers, Université d'Angers, INSERM Unité 1232, LabEx IGO 'Immuno-Graft-Onco', Angers, France., Dimitrov JD; Institut National de la Santé et de la Recherche Médicale and Centre de Recherche des Cordeliers, Equipe-Immunopathologie et Immunointervention Thérapeutique, Sorbonne Université, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France., Benveniste O; Département de Médecine Interne et Immunologie Clinique, Hôpital Pitié-Salpêtrière, AP-HP, Paris, France; Sorbonne Université, Institut National de la Santé et de la Recherche Médicale Unité 974, Paris, France., Bruhns P; Institut Pasteur, Department of Immunology, Unit of Antibodies in Therapy and Pathology, Paris, France; INSERM, U1222, Paris, France., Kaveri SV; Institut National de la Santé et de la Recherche Médicale and Centre de Recherche des Cordeliers, Equipe-Immunopathologie et Immunointervention Thérapeutique, Sorbonne Université, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France., Bayry J; Institut National de la Santé et de la Recherche Médicale and Centre de Recherche des Cordeliers, Equipe-Immunopathologie et Immunointervention Thérapeutique, Sorbonne Université, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France. Electronic address: jagadeesh.bayry@crc.jussieu.fr.
Publikováno v: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2019 Aug; Vol. 144 (2), pp. 524-535.e8. Date of Electronic Publication: 2018 Dec 07.
Zobrazit plný text záznamu
9
Akademický článek
Topical application of human-derived Ig isotypes for the control of acute respiratory infection evaluated in a human CD89-expressing mouse model.
Autor: Koernig S; CSL Limited, Bio21 Institute, 30 Flemington Rd, Parkville, VIC, 3010, Australia. sandra.koernig@csl.com.au., Campbell IK; CSL Limited, Bio21 Institute, 30 Flemington Rd, Parkville, VIC, 3010, Australia., Mackenzie-Kludas C; Department of Microbiology and Immunology The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, 792 Elizabeth St, Melbourne, VIC, 3000, Australia., Schaub A; CSL Behring AG, Wankdorfstrasse 10, 3010, Bern, Switzerland., Loetscher M; CSL Behring AG, Wankdorfstrasse 10, 3010, Bern, Switzerland., Ching Ng W; Department of Microbiology and Immunology The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, 792 Elizabeth St, Melbourne, VIC, 3000, Australia., Zehnder R; CSL Behring AG, Wankdorfstrasse 10, 3010, Bern, Switzerland., Pelczar P; Center for Transgenic Models, Mattenstrasse 22, 4002, Basel, Switzerland., Sanli I; Center for Transgenic Models, Mattenstrasse 22, 4002, Basel, Switzerland., Alhamdoosh M; CSL Limited, Bio21 Institute, 30 Flemington Rd, Parkville, VIC, 3010, Australia., Ng M; CSL Limited, Bio21 Institute, 30 Flemington Rd, Parkville, VIC, 3010, Australia., Brown LE; Department of Microbiology and Immunology The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, 792 Elizabeth St, Melbourne, VIC, 3000, Australia., Käsermann F; CSL Behring AG, Wankdorfstrasse 10, 3010, Bern, Switzerland., Vonarburg C; CSL Behring AG, Wankdorfstrasse 10, 3010, Bern, Switzerland., Zuercher AW; CSL Behring AG, Wankdorfstrasse 10, 3010, Bern, Switzerland. adrian.zuercher@cslbehring.com.
Publikováno v: Mucosal immunology [Mucosal Immunol] 2019 Jul; Vol. 12 (4), pp. 1013-1024. Date of Electronic Publication: 2019 May 19.
Zobrazit plný text záznamu
10
Akademický článek
Topical application of nebulized human IgG, IgA and IgAM in the lungs of rats and non-human primates.
Autor: Vonarburg C; CSL Behring AG, Research, Bern, Switzerland. cedric.vonarburg@cslbehring.com., Loetscher M; CSL Behring AG, Research, Bern, Switzerland., Spycher MO; CSL Behring AG, Research, Bern, Switzerland., Kropf A; CSL Behring AG, Research, Bern, Switzerland., Illi M; CSL Behring AG, Research, Bern, Switzerland., Salmon S; Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY, 12208, USA., Roberts S; Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY, 12208, USA., Steinfuehrer K; PARI Pharma GmbH, Lochhamer Schlag 21, 82166, Gräfelfing, Germany., Campbell I; CSL Ltd., Research, Bio21 Institute, Parkville, Victoria, Australia., Koernig S; CSL Ltd., Research, Bio21 Institute, Parkville, Victoria, Australia., Bain J; CSL Behring GmbH, Pharmacology and Toxicology, Marburg, Germany., Edler M; CSL Behring AG, Research, Bern, Switzerland., Baumann U; Medizinische Hochschule Hannover, Hannover, Germany., Miescher S; CSL Behring AG, Research, Bern, Switzerland., Metzger DW; Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY, 12208, USA., Schaub A; CSL Behring AG, Research, Bern, Switzerland., Käsermann F; CSL Behring AG, Research, Bern, Switzerland., Zuercher AW; CSL Behring AG, Research, Bern, Switzerland.
Publikováno v: Respiratory research [Respir Res] 2019 May 22; Vol. 20 (1), pp. 99. Date of Electronic Publication: 2019 May 22.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje